NFKB1 and colorectal cancer: A previous study indicated that PA showed anti‐inflammatory activity by downregulating the extracellular signal‐regulated kinase (ERK)‐mediated nuclear factor kappa B (NF‐κB) pathway in tumour necrosis factor (TNF)‐α‐stimulated HT‐29 human colorectal cancer cells.20